Elevance Health (ELV) vs Humana (HUM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Humana (HUM) has outperformed Elevance Health (ELV) over the past year, gaining 34.3% versus a gain of 13.9%. Over five years, ELV leads with a +2.9% price change compared with -10.1% for HUM. Elevance Health is the larger company by market cap ($87.68 billion vs $47.61 billion), about 1.8 times the size.
On valuation, Elevance Health trades at a lower forward P/E (13.7x vs 23.9x for Humana). Elevance Health offers the higher dividend yield (1.70% vs 0.89%). Elevance Health converts more of its revenue into profit, with a net margin of 2.8% versus 0.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELV | HUM |
|---|---|---|
| Share price | $404.31 | $396.51 |
| Market cap | $87.68B | $47.61B |
| 1-day change | +1.05% | -1.92% |
| YTD return | +16.12% | +54.81% |
| 1-year return | +13.87% | +34.30% |
| 5-year return | +2.86% | -10.09% |
| P/E ratio (TTM) | 17.90 | 37.48 |
| Forward P/E | 13.69 | 23.90 |
| EPS (TTM) | $22.59 | $10.58 |
| Dividend yield | 1.70% | 0.89% |
| Annual dividend | $6.86 | $3.54 |
| Revenue (latest FY) | $199.13B | $129.66B |
| Revenue growth (YoY) | +12.49% | +10.11% |
| Net income (latest FY) | $5.66B | $1.19B |
| Gross margin | 89.36% | — |
| Operating margin | 3.62% | 2.09% |
| Net margin | 2.84% | 0.92% |
| 52-week high | $436.24 | $428.88 |
| 52-week low | $274.84 | $163.11 |
| Distance from 52-week high | -7.32% | -7.55% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +11.67% | +6.87% |
| Average volume | 1.20M | 1.23M |
| Shares outstanding | 216.87M | 120.08M |
| Employees | 96,129 | 67,060 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HUM has outperformed ELV by 20.4 percentage points over the past year.
- Humana trades at a higher earnings multiple (37.5x vs 17.9x trailing P/E).
About Elevance Health
ELV stock →Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.
Health Care · Medical Specialities · 96,129 employees
About Humana
HUM stock →Humana Inc. provides medical and specialty insurance products in the United States.
Health Care · Medical Specialities · 67,060 employees
ELV vs HUM FAQ
Which is bigger, Elevance Health or Humana?
Elevance Health (ELV) is larger, with a market capitalization of $87.68B compared with $47.61B for Humana (HUM).
Which stock has performed better over the past year, ELV or HUM?
HUM returned +34.30% over the past 12 months, compared with +13.87% for ELV (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ELV or HUM?
ELV has the lower trailing P/E at 17.9, versus 37.5 for HUM. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Elevance Health or Humana?
Elevance Health has the higher yield at 1.70%, compared with 0.89% for Humana.
Are Elevance Health and Humana in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.